Capital Fund Management S.A. Vertex Pharmaceuticals Inc Transaction History

Capital Fund Management S.A.

$33.7 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $25.1 Million - $27.4 Million	61,530 New	61,530 $25.7 Million
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $3.3 Million - $3.89 Million	-17,577 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $7.64 Million - $8.9 Million	-36,888 Reduced 67.73%	17,577 $3.78 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $2.83 Million - $3.77 Million	-13,651 Reduced 20.04%	54,465 $12.9 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $12.5 Million - $14.8 Million	48,783 Added 252.33%	68,116 $18.5 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $2.01 Million - $2.63 Million	8,901 Added 85.32%	19,333 $5.61 Million
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $1.74 Million - $2.34 Million	10,432 New	10,432 $2.28 Million
Q2 2019 Aug 12, 2019	SELL	$164.61 - $190.37 $2.21 Million - $2.55 Million	-13,413 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$163.73 - $194.7 $10.2 Million - $12.1 Million	-62,323 Reduced 82.29%	13,413 $2.47 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $922,397 - $1.17 Million	6,072 Added 8.72%	75,736 $12.6 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $7.36 Million - $8.45 Million	-43,864 Reduced 38.64%	69,664 $13.4 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $9.08 Million - $10.6 Million	62,300 Added 121.61%	113,528 $19.3 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $25.4 Million - $29.7 Million	-167,638 Reduced 76.59%	51,228 $8.35 Million
Q4 2017 Feb 09, 2018	BUY	$137.28 - $155.55 $7.78 Million - $8.82 Million	56,700 Added 34.96%	218,866 $32.8 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $24 Million - $26.3 Million	162,166	162,166 $24.7 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

Capital World Investors Los Angeles, CA

26.7M
Shares

$12.7 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$10.9 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.1 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.56 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.05 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account